A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia
Clinical trial NCT04158687 · COMPLETED
Trial details
- NCT number
- NCT04158687
- Sponsor
- Concert Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-26
- Primary completion
- 2020-12-22
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.